简介：
Overview
This study develops a protocol to establish and maintain lacrimal gland organoids from both mouse and human tissues. The organoids enable exploration of genetic factors influencing lacrimal gland homeostasis and potential applications in regenerative medicine.
Key Study Components
Research Area
- Regenerative medicine
- Genetics
- Cell biology
Background
- Lacrimal gland organoids are derived from adult stem cells.
- These organoids provide a model for studying healthy lacrimal gland epithelial cells.
- They have potential therapeutic roles in treating dry eye disease.
Methods Used
- Tissue digestion, cell dissociation, and organoid formation.
- Mouse and human lacrimal gland models.
- Electroporation and time-lapse microscopy for monitoring organoid development.
Main Results
- Successful establishment of cystic organoids from both mouse and human tissue.
- Organ development observed in culture, showing differentiation capabilities.
- Organoid transplantation demonstrated the feasibility of applying this technology in vivo.
Conclusions
- The study provides a comprehensive method for generating lacrimal gland organoids.
- These organoids can serve as models for understanding lacrimal gland function and disease.
What are lacrimal gland organoids?
Lacrimal gland organoids are three-dimensional structures derived from lacrimal gland tissues that mimic the cellular behavior of the gland.
How can these organoids be used in research?
They can be used to study genetic influences on gland function and to develop therapies for conditions like dry eye disease.
What is the significance of using both mouse and human tissues?
Using both tissue types allows for comparative studies and enhances the translational potential of the findings.
What are the key steps in the protocol?
The protocol includes tissue preparation, cell dissociation, organoid culturing, and eventual transplantation.
What technologies are involved in monitoring the organoids?
Time-lapse microscopy is used to observe organoid development over time.
What is the viability of using these organoids for therapeutic purposes?
These organoids hold promise for regenerative applications in treating lacrimal gland-related diseases.
Can these organoids be genetically modified?
Yes, the protocol includes methods for genetically modifying the organoids using electroporation.
繁體中文
